References
- Kim H. Composite lymphoma and related disorders. Am J Clin Pathol 1993; 99(4):445-51; PMID:8475911; http://dx.doi.org/10.1093/ajcp/99.4.445
- Micallef IN, Kirk A, Norton A, Foran JM, Rohatiner AZ, Lister TA. Peripheral t-cell lymphoma following rituximab therapy for b-cell lymphoma. Blood 1999; 93(7):2427-8; PMID:10215354
- Kilner MF, Merante S, Svec A. The development of peripheral T-cell lymphoma after successful treatment for diffuse large B-cell lymphoma in a patient with suspected adult onset immunodeficiency: more questions than answers? BMJ Case Rep 2013; 2013:pii: bcr2013200079; PMID:24343800; http://dx.doi.org/10.1136/bcr-2013-200079
- Tarella C, Passera R, Magni M, Benedetti F, Rossi A, Gueli A, Patti C, Parvis G, Ciceri F, Gallamini A, et al. Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma. J Clin Oncol 2011; 29(7):814-24; PMID:21189387; http://dx.doi.org/10.1200/JCO.2010.28.9777